U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06805890) titled 'Study of Tissue Repair in Inflammatory Bowel Disease Exploiting Organoid Technology' on Jan. 28.
Brief Summary: Inflammatory Bowel Diseases (IBD) are chronic inflammations of the gastrointestinal tract. Regardless of the etiology, a common trait of IBD pathogenesis is the inflammatory damage inflicted on the intestinal mucosa and the loss of intestinal epithelial barrier integrity. Therefore, understanding the mechanisms that govern IEC's capacity to maintain barrier function and to orchestrate mucosal healing is considered a major goal in translational research. We are interested in understanding how the inflammatory environment pre...